Gilgamesh Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
Gilgamesh Pharmaceuticals has raised $80.1M across 4 funding rounds on record, the most recent a Series A of $60.0M announced in Mar 2026.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Gilgamesh Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Gilgamesh Pharmaceuticals Funding Rounds
1 of 4 rounds was announced without a disclosed amount and is excluded from the total.
Gilgamesh Pharmaceuticals announced an undisclosed round in Nov 2022; the amount was not disclosed.
1.3 years later, an undisclosed round of $14.0M was announced in Mar 2024.
1.9 years later, an undisclosed round of $6.1M was announced in Feb 2026.
1 month later, a Series A of $60.0M was announced in Mar 2026.
Gilgamesh Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Gilgamesh Pharmaceuticals Funding Compared to Other Biotechnology Startups
Gilgamesh Pharmaceuticals' latest round of $60.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Gilgamesh Pharmaceuticals in Biotechnology and New York
Companies Similar to Gilgamesh Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Gilgamesh Pharmaceuticals Funding FAQs
What does Gilgamesh Pharmaceuticals do?
Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy. Mental health worldwide has reached epidemic proportions and novel treatments have not kept pace with the urgent need to treat depression, anxiety, drug addiction and many other devastating diseases. Our purpose is to accelerate treatments and fundamentally improve mental health.
How much funding has Gilgamesh Pharmaceuticals raised?
Gilgamesh Pharmaceuticals has raised $80.1M across 4 rounds on record. The most recent is a Series A of $60.0M announced in Mar 2026.
When did Gilgamesh Pharmaceuticals last raise funding?
Gilgamesh Pharmaceuticals' most recent funding round on record is a Series A of $60.0M, announced in Mar 2026.
Who founded Gilgamesh Pharmaceuticals?
FundedIQ lists Dalibor Sames (Founder), Jonathan Sporn (Founder) at Gilgamesh Pharmaceuticals.
Where is Gilgamesh Pharmaceuticals headquartered?
Gilgamesh Pharmaceuticals is based in New York, United States.
How many employees does Gilgamesh Pharmaceuticals have?
Gilgamesh Pharmaceuticals is in the 11-50 employee band.
How does Gilgamesh Pharmaceuticals' funding compare to other Biotechnology startups?
Gilgamesh Pharmaceuticals' latest round of $60.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Gilgamesh Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Gilgamesh Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.